Photo via NBC News

New cervical cancer guidance to favor HPV screening over traditional Pap tests

Read the original at NBC News ↗
Cite

Jr., B. L. (2026, November 20). New cervical cancer guidance to favor HPV screening over traditional Pap tests. NBC News. https://www.nbcnews.com/health/womens-health/cervical-cancer-screening-federal-guidance-hpv-tests-pap-smear-rcna610282

Dated from the outlet's own feed. Check the original for its byline.

NBC News · collected 2026-11-20 · by Berkeley Lovelace Jr.

Quick Summary

Federal guidance may soon recommend that women aged 30 to 65 undergo HPV testing instead of traditional Pap smears for cervical cancer screening. This change could also include the option for self-administered HPV tests, which could increase accessibility for millions of women. The shift is based on evidence suggesting HPV tests detect precancerous changes more accurately and earlier than Pap tests, as highlighted in a 2018 study published in the Journal of the American Medical Society that involved over 19,000 participants. This new recommendation by the U.S. Preventive Services Task Force could significantly alter how cervical cancer is screened in the United States.
Written by AI on 2026-11-21, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

The U.S. Preventive Services Task Force is poised to recommend HPV screening over traditional Pap tests for women aged 30 to 65, a significant shift in cervical cancer detection methods. This decision, which was voted on behind closed doors at a two-day meeting, is expected to affect millions of women. The task force's recommendation, once finalized, will likely be covered by most private insurers at no cost to patients under the Affordable Care Act. Robert Smith, a cancer epidemiologist and senior vice president at the American Cancer Society, noted that self-administered HPV tests are accurate and easily conducted. This change reflects recent research indicating a decline in early cervical cancer detection efforts in the U.S. Human papillomavirus (HPV) is the leading cause of cervical cancer and the most common sexually transmitted infection.

Written for “Cervical Cancer Screening Guidance Updated” on 2026-11-21, grounded in this article and the 0 other(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.

Story

Cervical Cancer Screening Guidance Updated
Health · 1 article(s) covering the same event.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
38
sentences that state something as happening or true
Uncertain
21%
8 of 38 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
74/100
NBC News's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-21 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

NBC News · 2731 article(s) · 5 correction(s) detected
Running correction rate · 5 correction(s)

Who wrote this

Berkeley Lovelace Jr.
11 article(s) here · 1 carrying a prediction
Women can also opt for a self-administered HPV test, a major change from the U.S. Preventive Services Task Force that could affect how millions of women are screened for cervical cancer.
Previous research has found that GLP-1 use may increase the risk of NAION, and Lilly has said it was aware of studies on the potential link.
Democrats’ victories in the midterm elections could have a major impact on Americans’ healthcare, from how much people pay for health insurance and prescription drugs to what coverage is available to them, according to health policy experts and former White House advisers.
“Who knows who will cover me in 2027 or how much more it’ll cost,” Mroch said.
In a notice filed Wednesday, the agency said it would exercise “enforcement discretion,” meaning it will not take legal action against compounding pharmacies that make the six unapproved peptides.
Researchers focused on those drugs because patients don’t have the option of switching to cheaper versions, meaning the discounts offered through TrumpRx could have a greater impact on what they pay.
She added, however, that retatrutide “may be too strong for some patients,” particularly those with only mild diabetes or slightly elevated weight.
Dr. Heidi Overton, a fierce opponent of abortion rights, is set to appear before senators Thursday for her confirmation hearing to lead the Food and Drug Administration.
The cuts, Vance said, would save U.S. taxpayers $2.2 billion.
It’s too early to predict how severe the upcoming flu season will be and the Centers for Disease Control and Prevention hasn’t started tracking cases yet.
Also by Berkeley Lovelace Jr.
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 11 articles by Berkeley Lovelace Jr. →

Topics

Yale School of Medicine the American Cancer Society the Journal of the American Medical Association the U.S. Preventive Services Task Force the United States

Subjects

Smith PERSON · 2× Health ORG · 1× Robert Smith PERSON · 1× Sangini Sheth PERSON · 1× Sheth PERSON · 1× Yale School of Medicine ORG · 1× the American Cancer Society ORG · 1× the Journal of the American Medical Association ORG · 1× the U.S. Preventive Services Task Force ORG · 1× the United States GPE · 1×

Narrative

Robert Smith, a cancer epidemiologist and senior vice president of early cancer detection science for the American Cancer Society, said, “Collecting a specimen is pretty easily accomplished and it really has equivalent accuracy with a physician-collected specimen.”
framing: mixed · carried by 1 article(s) · first seen 2026-11-21
Women can also opt for a self-administered HPV test, a major change from the U.S. Preventive Services Task Force that could affect how millions of women are screened for cervical cancer.

Claims (38 extracted, 8 hedged)

For the first time, federal gudiance is poised to steer women ages 30 to 65 toward an HPV test rather than the traditional Pap smear. asserted
gudiance → poise → smear
Women can also opt for a self-administered HPV test, a major change from the U.S. Preventive Services Task Force that could affect how millions of women are screened for cervical cancer. uncertain
millions → opt → cancer
Cervical cancer is one of the most preventable cancers, although recent research suggests that the United States is backsliding in efforts to detect the disease early. uncertain
States → suggest → disease
Human papillomavirus, the virus behind virtually all cervical cancers, is the most common sexually transmitted infection. asserted
papillomavirus → transmit → cancers
The recommendation, which isn’t yet final, came Friday when panel members voted behind closed doors at the conclusion of a two-day meeting, according to a person familiar with the vote. uncertain
members → come → vote
The person asked to speak on the condition of anonymity because they were not authorized to speak publicly. asserted
they → ask → anonymity
The recommendation from the task force — an outside group made up mostly of primary care physicians — carries real weight. asserted
recommendation → make → weight
Under the Affordable Care Act, most private insurers generally have to cover services the panel recommends at no cost to patients. asserted
panel → have → patients
A spokesperson for the task force did not respond to a request for comment. asserted
spokesperson → respond → comment
Under the task force’s previous recommendations, women ages 30 to 65 could choose among three options: a Pap test every three years, an HPV test every five years or both every five years. uncertain
women → choose → options
The task force continues to recommend that women ages 21 to 29 get a Pap test every three years. asserted
women → continue → test
Dr. Sangini Sheth, an associate professor of obstetrics, gynecology and reproductive sciences at Yale School of Medicine, said the self-collection option could increase women’s access to screening. uncertain
option → say → screening
“The self-collection is great for people who might have a hard time tolerating a speculum exam, and it also broadens our ability to offer screening in different scenarios, through mobile health clinics, maybe through a freestanding lab or in medical specialty offices where traditionally pelvic exams aren’t being done,” she said. uncertain
she → have → offices
Robert Smith, a cancer epidemiologist and senior vice president of early cancer detection science for the American Cancer Society, said, “Collecting a specimen is pretty easily accomplished and it really has equivalent accuracy with a physician-collected specimen.” asserted
it → say → specimen
For decades, a Pap test, which looks for abnormal or precancerous cells on the cervix, has been the main way doctors screen for cervical cancer. asserted
doctors → look → cancer
An HPV test instead looks for high-risk strains of HPV, often visible before cell abnormalities develop, which allows women to go longer between tests. asserted
women → look → tests
A 2018 study published in the Journal of the American Medical Association found that HPV tests detect precancerous changes to the cervix earlier and more accurately than Pap tests do. asserted
tests → publish → cervix
The study included more than 19,000 women. asserted
study → include → women
Smith said some women put off Pap tests because they’re uncomfortable or find the exam invasive, especially when it’s done by a male doctor. asserted
it → say → doctor
Self-collected HPV tests — which use a simple vaginal swab rather than a speculum — are generally more comfortable. asserted
which → collect → swab
“We expect [the self-collecting test] to increase screening,” he added. asserted
he → expect → screening
Many women get both tests together, but most of the benefit comes from the HPV test, Sheth said. asserted
Sheth → get → test
The Pap test alone misses a significant share of abnormalities, she said, catching roughly 50% to 70% of them. asserted
she → miss → them
Women who skip HPV tests are far more likely to have an HPV-related problem go undetected. asserted
problem → skip → tests
“There’s really not a downside to not having that Pap,” she said. asserted
she → ’ → Pap
“It is superior to cost-testing,” Smith said, referring to the HPV test. asserted
Smith → say → test
Task force recommendations are typically final once they’re published, and it’s not clear when that will happen. asserted
that → publish → ?
It’s also unclear whether Health Secretary Robert F. Kennedy Jr. will need to sign off or seek to make changes after the Supreme Court ruled last year that he has authority over the panel. uncertain
he → ’ → panel
In that case, brought by a Christian-owned business that objected to covering an HIV prevention drug, the court upheld the panel’s authority because the health secretary can remove its members and review their recommendations. asserted
secretary → bring → recommendations
In September, Kennedy reshaped the panel, naming eight new members, some of whom own stock in companies that make drugs and other products affected by the group’s decisions, according to documents reviewed by The New York Times. uncertain
that → reshape → Times
NBC News has not independently reviewed the documents. asserted
News → review → documents
A spokesperson for the Department of Health and Human Services did not immediately respond to a request for comment. asserted
spokesperson → respond → comment
Smith said the task force’s recommendation brings it closer to the American Cancer Society’s guidelines, which began prioritizing HPV testing in 2020. asserted
which → say → 2020
There are still some differences: The cancer society recommends starting screening at 25 with the HPV test, while the task force recommends starting at 21 with Pap tests and switching to HPV testing at 30. asserted
force → be → 30
And for women who collect their own samples, the cancer society recommends testing every three years, not five, because it wants more long-term data before recommending a longer gap, Smith said. asserted
Smith → collect → gap
The task force on Thursday also clarified which women should stop screening at age 65: only if they’ve had several negative results in a row over the past decade. asserted
they → clarify → decade
Women who haven’t should keep getting screened, the panel said. asserted
panel → have → ?
In a statement, a spokesperson for the American College of Obstetricians and Gynecologists, said the group is “monitoring the USPSTF process to amend cervical cancer screening recommendations and will evaluate the final proposed changes when available.” asserted
group → say → changes
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support